EXO Biologics S.A.
EXO Biologics S.A.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, Infections, Lung Injury, Ventilator-Induced Lung Injury, bronchopulmonary dysplasia, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 1 / Phase 2 | 2024-09-19 | NCT06279741 |